$226 Million is the total value of Alerce Investment Management, L.P.'s 7 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMWL | AMERICAN WELL CORPcl a | $109,444,000 | -31.4% | 6,300,773 | 0.0% | 48.42% | -23.0% | |
| ANNX | ANNEXON INC | $54,427,000 | +11.2% | 1,954,978 | 0.0% | 24.08% | +25.0% | |
| ALRN | Buy | AILERON THERAPEUTICS INC | $23,752,000 | +200.1% | 16,609,449 | +118.3% | 10.51% | +237.2% |
| AKBA | AKEBIA THERAPEUTICS INC | $15,749,000 | +20.9% | 4,652,561 | 0.0% | 6.97% | +35.8% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $10,247,000 | -24.0% | 2,227,500 | 0.0% | 4.53% | -14.6% | |
| ARPO | AERPIO PHARMACEUTICALS INC | $7,252,000 | +31.6% | 5,621,835 | 0.0% | 3.21% | +47.9% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $5,146,000 | -5.9% | 126,270 | 0.0% | 2.28% | +5.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMERICAN WELL CORP | 12 | Q3 2023 | 62.9% |
| ANNEXON INC | 12 | Q3 2023 | 35.9% |
| AKEBIA THERAPEUTICS INC | 12 | Q3 2023 | 31.6% |
| ASSEMBLY BIOSCIENCES INC | 12 | Q3 2023 | 8.7% |
| AADI BIOSCIENCES INC | 9 | Q3 2023 | 24.1% |
| AILERON THERAPEUTICS INC | 8 | Q3 2022 | 14.4% |
| GLOBAL BLOOD THERAPEUTICS IN | 8 | Q3 2022 | 23.4% |
| AILERON THERAPEUTICS INC | 4 | Q3 2023 | 2.3% |
| AERPIO PHARMACEUTICALS INC | 3 | Q2 2021 | 5.2% |
View Alerce Investment Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-04 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-09 |
| 13F-HR | 2021-11-15 |
View Alerce Investment Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.